Intergalactic Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 27

Employees

  • Latest Deal Type
  • M&A

Intergalactic Therapeutics General Information

Description

Developer of a focal non-viral gene therapy designed to overcome the limitations of viral-based gene therapy. The company's therapy uses synthetic biology and engineered gene circuits to make covalently closed and circular deoxyribonucleic acid molecules, providing healthcare professionals with access to new gene therapies which safety issues, and technical obstacles have beset.

Contact Information

Website
www.intergalactictx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 150 Cambridge Drive
  • Suite 800
  • Cambridge, MA 02140
  • United States
Primary Industry
Biotechnology
Acquirer
Aldevron
Vertical(s)
Life Sciences
Corporate Office
  • 150 Cambridge Drive
  • Suite 800
  • Cambridge, MA 02140
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intergalactic Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Mar-2024 Completed Generating Revenue
1. Buyout/LBO 13-Mar-2020 Completed Generating Revenue
To view Intergalactic Therapeutics’s complete valuation and funding history, request access »

Intergalactic Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Intergalactic Therapeutics’s complete cap table history, request access »

Intergalactic Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a focal non-viral gene therapy designed to overcome the limitations of viral-based gene therapy. The compan
Biotechnology
Cambridge, MA
27 As of 2023

Somerville, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intergalactic Therapeutics Competitors (73)

One of Intergalactic Therapeutics’s 73 competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Ring Therapeutics Venture Capital-Backed Cambridge, MA
WaVe Life Sciences Formerly VC-backed Cambridge, MA
Casma Therapeutics Venture Capital-Backed Cambridge, MA
EdiGene Venture Capital-Backed Beijing, China
You’re viewing 5 of 73 competitors. Get the full list »

Intergalactic Therapeutics Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Intergalactic Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024064608-A2 Best1 vectors and uses thereof Inactive 20-Sep-2022
WO-2024052734-A2 Respiratory vectors and uses thereof Inactive 13-Jul-2022
WO-2024052734-A3 Respiratory vectors and uses thereof Inactive 13-Jul-2022
WO-2024011203-A2 Ocular vectors and uses thereof Inactive 07-Jul-2022
WO-2024011203-A3 Ocular vectors and uses thereof Inactive 07-Jul-2022 A61K48/005
To view Intergalactic Therapeutics’s complete patent history, request access »

Intergalactic Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intergalactic Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apple Tree Partners (ATP) Venture Capital Majority
To view Intergalactic Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Intergalactic Therapeutics FAQs

  • When was Intergalactic Therapeutics founded?

    Intergalactic Therapeutics was founded in 2020.

  • Where is Intergalactic Therapeutics headquartered?

    Intergalactic Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Intergalactic Therapeutics?

    Intergalactic Therapeutics has 27 total employees.

  • What industry is Intergalactic Therapeutics in?

    Intergalactic Therapeutics’s primary industry is Biotechnology.

  • Is Intergalactic Therapeutics a private or public company?

    Intergalactic Therapeutics is a Private company.

  • What is Intergalactic Therapeutics’s current revenue?

    The current revenue for Intergalactic Therapeutics is .

  • Who are Intergalactic Therapeutics’s investors?

    Apple Tree Partners (ATP) has invested in Intergalactic Therapeutics.

  • Who are Intergalactic Therapeutics’s competitors?

    Genetix Biotherapeutics, Ring Therapeutics, WaVe Life Sciences, Casma Therapeutics, and EdiGene are some of the 73 competitors of Intergalactic Therapeutics.

  • When was Intergalactic Therapeutics acquired?

    Intergalactic Therapeutics was acquired on 01-Mar-2024.

  • Who acquired Intergalactic Therapeutics?

    Intergalactic Therapeutics was acquired by Aldevron.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process